Application of d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) in transdermal and topical drug delivery systems (TDDS)

被引：24
作者：
Pham C.V. [1 ]
Cho C.-W. [1 ]
机构：
[1] College of Pharmacy, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon
来源：
Journal of Pharmaceutical Investigation | 2017年 / 47卷 / 2期
关键词：
Solubilizer; Topical; TPGS; Transdermal;
D O I：
10.1007/s40005-016-0300-x
中图分类号：
学科分类号：
摘要：
d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) is a water-soluble nonionic surfactant, which is prepared from the esterification of Vitamin E succinate with polyethylene glycol 1000. Due to unique amphiphilic structure, TPGS offers many essential properties such as solubilizer, penetration enhancer, stabilizer, emulsifier, antioxidant agent and protection of drug in micelles, which can be used for permeation of drug through skin or deposition of drug in skin. Especially, the applications of TPGS for various systems such as supersaturated system, solid lipid nanoparticles, gels, microemulsions, nanoemulsions and solid dispersions will be discussed in this review. © 2017, The Korean Society of Pharmaceutical Sciences and Technology.
引用
收藏
页码：111 / 121
页数：10
相关论文
共 62 条
[41]  
Neophytou C.M., Constantinou C., Papageorgis P., Constantinou A.I., D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells, Biochem Pharmacol, 89, pp. 31-42, (2014)
[42]  
Paudel K.S., Milewski M., Swadley C.L., Brogden N.K., Ghosh P., Stinchcomb A.L., Challenges and opportunities in dermal/transdermal delivery, Ther Deliv, 1, pp. 109-131, (2010)
[43]  
Physician’s desk reference, pp. 1396-1401, (2005)
[44]  
Pham J., Brownlow B., Elbayoumi T., Mitochondria-specific pro-apoptotic activity of genistein lipidic nanocarriers, Mol Pharm, 10, pp. 3789-3800, (2013)
[45]  
Pham J., Nayel A., Hoang C., Elbayoumi T., Enhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomas, Drug Deliv, 23, pp. 1514-1524, (2014)
[46]  
Rajebahadur M., Zia H., Nues A., Lee C., Mechanistic study of solubility enhancement of nifedipine using vitamin E TPGS or solutol HS-15, Drug Deliv, 13, pp. 201-206, (2006)
[47]  
Repka M.A., McGinity J.W., Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion, Int J Pharm, 202, pp. 63-70, (2000)
[48]  
Romero G.B., Arntjen A., Keck C.M., Muller R.H., Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability, Int J Pharm, 498, pp. 217-224, (2016)
[49]  
Santos P., Watkinson A.C., Hadgraft J., Lane M.E., Application of microemulsions in dermal and transdermal drug delivery, Skin Pharmacol Physiol, 21, pp. 246-259, (2008)
[50]  
Sheu M.T., Chen S.Y., Chen L.C., Ho H.O., Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol, J Control Rel, 88, pp. 355-368, (2003)
1234567